FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386960041> ?p ?o ?g. }

• W4386960041 endingPage "2597" @default.
• W4386960041 startingPage "2597" @default.
• W4386960041 abstract "Mometasone furoate (MF) is a kind of glucocorticoid with extensive pharmacological actions, including inhibiting tumor progression; however, the role of MF in head and neck squamous cell carcinoma (HNSCC) is still unclear. This study aimed to evaluate the inhibitory effect of MF against HNSCC and investigate its underlying mechanisms. Cell viability, colony formation, cell cycle and cell apoptosis were analyzed to explore the effect of MF on HNSCC cells. A xenograft study model was used to investigate the effect of MF on HNSCC in vivo. The core targets of MF for HNSCC were identified using network pharmacology analysis, TCGA database analysis and real-time PCR. Molecular docking was performed to determine the binding energy. Protein tyrosine phosphatase non-receptor type 11 (PTPN11)-overexpressing cells were constructed, and then, the cell viability and the expression levels of proliferation- and apoptosis-related proteins were detected after treatment with MF to explore the role of PTPN11 in the inhibitory effect of MF against HNSCC. After cells were treated with MF, cell viability and the number of colonies were decreased, the cell cycle was arrested and cell apoptosis was increased. The xenograft study results showed that MF could inhibit cell proliferation via promoting cell apoptosis in vivo. PTPN11 was shown to be the core target of MF against HNSCC via network pharmacology analysis, TCGA database analysis and real-time PCR. The molecular docking results revealed that PTPN11 exhibited the strongest ability to bind to MF. Finally, MF could attenuate the effects of increased cell viability and decreased cell apoptosis caused by PTPN11 overexpression, suggesting that MF can inhibit the progression of HNSCC by regulating PTPN11. MF targeted PTPN11, promoting cell cycle arrest and cell apoptosis, and consequently exerting effective anti-tumor activity." @default.
• W4386960041 created "2023-09-23" @default.
• W4386960041 creator A5011914561 @default.
• W4386960041 creator A5036130012 @default.
• W4386960041 creator A5041098733 @default.
• W4386960041 creator A5079512621 @default.
• W4386960041 creator A5082798405 @default.
• W4386960041 date "2023-09-22" @default.
• W4386960041 modified "2023-10-17" @default.
• W4386960041 title "Mometasone Furoate Inhibits the Progression of Head and Neck Squamous Cell Carcinoma via Regulating Protein Tyrosine Phosphatase Non-Receptor Type 11" @default.
• W4386960041 cites W2014229457 @default.
• W4386960041 cites W2033425868 @default.
• W4386960041 cites W2034192147 @default.
• W4386960041 cites W2053420373 @default.
• W4386960041 cites W2055475863 @default.
• W4386960041 cites W2070949410 @default.
• W4386960041 cites W2088069828 @default.
• W4386960041 cites W2115533799 @default.
• W4386960041 cites W2135056614 @default.
• W4386960041 cites W2159384392 @default.
• W4386960041 cites W2468923062 @default.
• W4386960041 cites W2604177176 @default.
• W4386960041 cites W2778965629 @default.
• W4386960041 cites W2790685396 @default.
• W4386960041 cites W2793773960 @default.
• W4386960041 cites W2803222616 @default.
• W4386960041 cites W2918864820 @default.
• W4386960041 cites W2996845434 @default.
• W4386960041 cites W3029948889 @default.
• W4386960041 cites W3085529787 @default.
• W4386960041 cites W3127872243 @default.
• W4386960041 cites W3128646645 @default.
• W4386960041 cites W3130233413 @default.
• W4386960041 cites W3131983302 @default.
• W4386960041 cites W3147724077 @default.
• W4386960041 cites W3153703639 @default.
• W4386960041 cites W3159329285 @default.
• W4386960041 cites W3184718508 @default.
• W4386960041 cites W3189585111 @default.
• W4386960041 cites W3193470707 @default.
• W4386960041 cites W4309732865 @default.
• W4386960041 cites W4322499723 @default.
• W4386960041 cites W4322758446 @default.
• W4386960041 cites W4360997906 @default.
• W4386960041 cites W4361245262 @default.
• W4386960041 cites W4380590300 @default.
• W4386960041 cites W4382069025 @default.
• W4386960041 cites W4382983133 @default.
• W4386960041 doi "https://doi.org/10.3390/biomedicines11102597" @default.
• W4386960041 hasPublicationYear "2023" @default.
• W4386960041 type Work @default.
• W4386960041 citedByCount "0" @default.
• W4386960041 crossrefType "journal-article" @default.
• W4386960041 hasAuthorship W4386960041A5011914561 @default.
• W4386960041 hasAuthorship W4386960041A5036130012 @default.
• W4386960041 hasAuthorship W4386960041A5041098733 @default.
• W4386960041 hasAuthorship W4386960041A5079512621 @default.
• W4386960041 hasAuthorship W4386960041A5082798405 @default.
• W4386960041 hasBestOaLocation W43869600411 @default.
• W4386960041 hasConcept C121608353 @default.
• W4386960041 hasConcept C1491633281 @default.
• W4386960041 hasConcept C190283241 @default.
• W4386960041 hasConcept C2776530083 @default.
• W4386960041 hasConcept C2776833033 @default.
• W4386960041 hasConcept C29537977 @default.
• W4386960041 hasConcept C502942594 @default.
• W4386960041 hasConcept C53227056 @default.
• W4386960041 hasConcept C54355233 @default.
• W4386960041 hasConcept C55493867 @default.
• W4386960041 hasConcept C62112901 @default.
• W4386960041 hasConcept C62478195 @default.
• W4386960041 hasConcept C85528070 @default.
• W4386960041 hasConcept C86803240 @default.
• W4386960041 hasConcept C95444343 @default.
• W4386960041 hasConceptScore W4386960041C121608353 @default.
• W4386960041 hasConceptScore W4386960041C1491633281 @default.
• W4386960041 hasConceptScore W4386960041C190283241 @default.
• W4386960041 hasConceptScore W4386960041C2776530083 @default.
• W4386960041 hasConceptScore W4386960041C2776833033 @default.
• W4386960041 hasConceptScore W4386960041C29537977 @default.
• W4386960041 hasConceptScore W4386960041C502942594 @default.
• W4386960041 hasConceptScore W4386960041C53227056 @default.
• W4386960041 hasConceptScore W4386960041C54355233 @default.
• W4386960041 hasConceptScore W4386960041C55493867 @default.
• W4386960041 hasConceptScore W4386960041C62112901 @default.
• W4386960041 hasConceptScore W4386960041C62478195 @default.
• W4386960041 hasConceptScore W4386960041C85528070 @default.
• W4386960041 hasConceptScore W4386960041C86803240 @default.
• W4386960041 hasConceptScore W4386960041C95444343 @default.
• W4386960041 hasFunder F4320321001 @default.
• W4386960041 hasIssue "10" @default.
• W4386960041 hasLocation W43869600411 @default.
• W4386960041 hasOpenAccess W4386960041 @default.
• W4386960041 hasPrimaryLocation W43869600411 @default.
• W4386960041 hasRelatedWork W2350294409 @default.
• W4386960041 hasRelatedWork W2350542818 @default.
• W4386960041 hasRelatedWork W2354128257 @default.
• W4386960041 hasRelatedWork W2354735832 @default.

• next